Skip Ribbon Commands
Skip to main content
Dr  Alvin Low Wei Xiang

Dr Alvin Low Wei Xiang

​MBBS (Singapore),MRCS (Edinburgh),FAMS (Singapore)

Associate Consultant

Sengkang General Hospital

Specialty: Urology

Conditions Treated by this Doctor:
Benign Prostatic Hyperplasia (BPH), Bladder Cancer, Kidney Cancer, Prostate Cancer, Testicular Cancer, Urinary Stone Disease.

Clinical Appointments

  • Associate Consultant Department of Urology Sengkang General HospitalSengkang General Hospital


​Dr Alvin Low is an Associate Consultant in the Urology Department, Sengkang General Hospital. He graduated from the Yong Loo Lin School of Medcine, National University of Singapore with a Bachelor of Medicine and Surgery (MBBS) in 2011. He completed his intercollegiate Membership of the Royal College of Surgeons (MRCS, Edinburgh) in 2013 followed by the Singhealth Urology Residency training and joined the Academy of Medicine, Singapore as a Fellow.


  • ​MBBS (Singapore): Yong Loo Lin School of Medicine, National University of Singapore
  • MRCS (Edinburgh): United Kingdom
  • FAMS (Singapore)

Professional Appointments and Committee Memberships

  • ​Clinical instructor, Duke-NUS
  • Adjunct Research Fellow, Duke-NUS
  • Clinical Lecturer, Yong Loo Lin School of Medicine, NUS
  • Clinical Teacher, Lee Kong Chian School of Medicine, NTU  
  • Member, Singapore Urological Association 
  • Member, European Association of Urology
  • Member, American Urology Association
  • Member, Royal College of Surgeons (Edinburgh)


  • ​Surgery ACP Seed Grant, 2018 
  • SGH Research Grant, 2019 
  • Service with a Heart award, 2019
  • Quality Improvement project - Significant Impact Award, 2020
  • Healthcare Product Design Award (SUTD), 2022

Research Interests


  1. ​Oncological outcomes following robotic-assisted radical prostatectomy in a multiracial Asian population. Alvin LWX, Gee SH, Hong HH, Christopher CW, Henry HS, Weber LK, Hoon TP, Shiong LL. J Robot Surg. 2015 Sep;9(3):201-9. 
  2. Ambulatory robot-assisted laparoscopic radical prostatectomy with extended recovery by total extraperitoneal approach. Alvin LWX, Chen K, Tan YG, Ng TK, Yuen JSP.  Int J Urol. 2021 May
  3. Sandwiched posterior-anterior reconstructed tissue-glued anastomosis (SPARTAN) in RARP: A consistently reproducible urethro-vesical anastomosis for early catheter removal and continence recovery. Alvin LWX, Tze K. Ng, John S.P. Yuen. Urology Video Journal, Volume 4, 2019
  4. Biomarkers for Precision Urothelial Carcinoma Diagnosis: Current Approaches and the Application of Single-Cell Technologies. Hong M, He G, Goh S, Alvin LWX, Tay KJ, Lim TKH, Yeong J, Khor LY, Lim TS. Cancers (Basel). 2021 Jan 12
  5. Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer. Front Lim CJ, Nguyen PHD, Wasser M, Kumar P, Lee YH, Nasir NJM, Chua C, Lai L, Hazirah SN, Loh JJH, Khor LY, Yeong J, Lim TKH, Alvin LWX, Albani S, Chong TW, Chew V. Immunol. 2021 Jan 29

Research Trials

  1. ​The Sonic Hedgehog link; histopathology and protein analysis of stented and non-stented paired porcine ureter 
  2. The Urinary Unknown; uncovering unknown urine/blood biomarkers of ureteric presenting and dilatation in pig to humans. 
  3. A novel technique to improve diagnostic accuracy of urine cytology and biomarkers in bladder cancer. 
  4. Investigating the role of PRL-3 as urinary biomarker and therapeutic target in kidney (RCC) and bladder cancers.